We show that 22E6 blocks CD73 in a non-competitive manner, that it directly induces apoptosis in triple-negative breast cancer cells in vitro, and that it has a transient antitumor effect on patient-derived acute lymphatic leukemia (ALL) cells in vivo. Here, NT5E is linked to acute lymphoblastic leukemia.